Institutional Ownership
Astrazeneca PLC
CUSIP 046353108SPONSORED ADRAZNQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
60
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Foresight Global Investors, Inc. | 145.3K | $28.66M |
| 2 | Edentree Asset Management Ltd | 117.2K | $22.70M |
| 3 | Axiom Investors LLC /De | 62.7K | $12.37M |
| 4 | Banque Transatlantique SA | 62.2K | $12.06M |
| 5 | Capital Fund Management S.A. | 51.2K | $10.09M |
| 6 | Mengis Capital Management, Inc. | 46.7K | $9.21M |
| 7 | Ethic Inc. | 35.6K | $7.02M |
| 8 | Wahed Invest LLC | 35.2K | $6.81M |
| 9 | Pinkerton Wealth, LLC | 69.3K | $6.37M |
| 10 | Stanley-Laman Group, Ltd. | 24.1K | $4.74M |